======= MYL3 ======= == Gene Information == * **Official Symbol**: MYL3 * **Official Name**: myosin light chain 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4634|4634]] * **UniProt**: [[https://www.uniprot.org/uniprot/P08590|P08590]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MYL3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MYL3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/160790|Open OMIM]] == Function Summary == * **Entrez Summary**: MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Regulatory light chain of myosin. Does not bind calcium. No Pfam Domain information is available for this gene. |myosin II heavy chain binding| |A band| |muscle myosin complex| |I band| |regulation of the force of heart contraction| |actin monomer binding| |actin-myosin filament sliding| |muscle filament sliding| |structural constituent of muscle| |ventricular cardiac muscle tissue morphogenesis| |sarcomere| |ventricular cardiac muscle tissue development| |positive regulation of ATPase activity| |cardiac muscle tissue morphogenesis| |cardiac ventricle morphogenesis| |cardiac muscle contraction| |muscle tissue morphogenesis| |regulation of ATPase activity| |muscle organ morphogenesis| |heart contraction| |actin-mediated cell contraction| |regulation of striated muscle contraction| |heart process| |striated muscle contraction| |actin filament-based movement| |cardiac chamber morphogenesis| |cardiac ventricle development| |regulation of muscle contraction| |cardiac muscle tissue development| |cardiac chamber development| |regulation of muscle system process| |regulation of heart contraction| |muscle contraction| |heart morphogenesis| |striated muscle tissue development| |regulation of blood circulation| |muscle organ development| |muscle tissue development| |muscle system process| |blood circulation| |circulatory system process| |muscle structure development| |heart development| |tissue morphogenesis| |actin filament-based process| |regulation of system process| |calcium ion binding| |positive regulation of hydrolase activity| |circulatory system development| |animal organ morphogenesis| |regulation of hydrolase activity| |positive regulation of catalytic activity| |movement of cell or subcellular component| |tissue development| |positive regulation of molecular function| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11331 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}